Idhifa (enasidenib)

pCPA File Number: 21152
Negotiation Status:
Negotiations were not pursued
Indication(s):
Acute Myeloid Leukemia (AML)
Sponsor/Manufacturer:
Celgene Inc.
CDA-AMC Project Number:
PC0144-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded: